Antisera and blood fractions imports in Libya: data, top suppliers and prices
Libya imported $25.7 million of antisera and blood fractions in 2024 (41 tonnes). Value rose 20% on 2023. Over 2017-2024 the trade grew strongly, by about 14% a year on average.
Public statistics, latest complete year (2024). Values in US dollars. Page updated .
Imports by year, 2017-2024
Hover or tap a year for detail.
Year by year
| Year | Value | Quantity |
|---|---|---|
| 2024 | $25.7M | 41 t |
| 2023 | $21.5M | 50 t |
| 2022 | $15.4M | 42 t |
| 2021 | $22.0M | 278 t |
| 2020 | $12.1M | 54 t |
| 2019 | $26.2M | 84 t |
| 2018 | $19.2M | 427 t |
| 2017 | $10.3M | 1.1K t |
Where Libya imports antisera and blood fractions from
The largest suppliers were Germany (47%), Austria (34%), South Korea (13%). Among the main suppliers, Austria grew fastest (+558% on the year before).
| Supplier country | Value | Share |
|---|---|---|
| Germany | $12.0M | 47% |
| Austria | $8.7M | 34% |
| South Korea | $3.2M | 13% |
| United States | $1.2M | 4.6% |
| India | $214K | 0.8% |
| France | $178K | 0.7% |
| Italy | $148K | 0.6% |
| Spain | $17K | 0.1% |
| Tunisia | $14K | 0.1% |
| Czech Republic | $12K | 0.1% |
Average import price per kg
The average declared value was about $629.44 per kg, 133% above the world average of $269.95. This usually points to higher-grade or processed goods.
Declared value divided by weight, all 2024 shipments. Prices per shipment and per company are in EximDataX.
Who is behind these numbers in Libya?
The shipment records behind Libya antisera and blood fractions imports (HS 3002.12): companies, dates, quantities and declared values.
Shipment records are in the platform
Tell us what you trade and we will show you the latest records on a live call.
Mirror data: built from the shipment records of the countries that trade with it.
Source: CEPII BACI (reconciled UN Comtrade data), HS 2017 edition, release 202601, Etalab Open Licence 2.0. Annual values in US dollars at the customs border; quantities in tonnes where reported. HS 3002.12: Blood, human or animal, antisera, other blood fractions and immunological products: antisera and other blood fractions.
Common questions
What is the value of antisera and blood fractions imported by Libya?
Libya imported antisera and blood fractions worth $25.7 million in 2024, the latest year with complete public data, about 41 tonnes. That ranks it 68th of 213 countries worldwide, with 0% of world imports. The value was up 20% on 2023.
Which countries supply antisera and blood fractions to Libya?
Germany was the largest supplier with 47% of the value ($12.0 million), followed by Austria (34%) and South Korea (13%). The top three together account for 93%, out of 14 supplier countries in total. Italy grew fastest among the top ten, up 712% on the year.
What is the average import price of antisera and blood fractions per kg?
The average declared import value was about $629.44 per kg in 2024, 133% above the world average of $269.95 per kg. Declared value divided by weight mixes every grade, so read it as a benchmark rather than a quote.
How have imports of antisera and blood fractions to Libya changed since 2017?
Imports went from $10.3 million in 2017 to $25.7 million in 2024, an increase of 151%. The peak was 2019 at $26.2 million. Over 8 years the average was $19.1 million a year.
What is the HS code for antisera and blood fractions?
The HS code for antisera and blood fractions is subheading 3002.12. It sits in HS chapter 30 (pharmaceutical products). The full list of codes and descriptions is on the HS 3002 page.
How can I find the companies behind this trade?
EximDataX rebuilds Libya trade from the customs records of its trading partners, so the companies shipping to and from it are visible. Ask for a live look at your product.
Same product, other countries
World antisera and blood fractions trade: top importers and exporters
See what your buyers are buying.Then decide.
Everything we show you comes from official customs filings — records, not claims. 30 minutes. Your shipment. Your HS code. Real platform. If you don’t see something new about your market by the end of the call, we walk away. No follow-ups.